Lombard Odier Asset Management (Switzerland) Sa Mirati Therapeutics, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.27 Billion
Q4 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $1.57 Million - $2.33 Million	42,999 Added 61.47%	112,952 $4.2 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $100,657 - $240,534	2,439 Added 3.61%	69,953 $3.17 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $489,744 - $713,627	-8,231 Reduced 10.87%	67,514 $4.72 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $1.44 Million - $3.25 Million	36,653 Added 93.76%	75,745 $5.09 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $6.27 Million - $12.5 Million	-82,644 Reduced 67.89%	39,092 $3.21 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $3.77 Million - $5.44 Million	28,579 Added 30.68%	121,736 $17.9 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $2.57 Million - $3.45 Million	19,447 Added 26.38%	93,157 $16.5 Million
Q2 2021 Aug 13, 2021	BUY	$144.0 - $179.73 $4.36 Million - $5.44 Million	30,282 Added 69.73%	73,710 $11.9 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $6.9 Million - $9.62 Million	43,428 New	43,428 $7.44 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account